Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714973 · ClinicalTrials.gov registry record · Phase 1
Study of ST266 Versus Saline in Treating Skin Irritation From Radiation
A Phase 1 study, sponsored by Noveome Biotherapeutics, formerly Stemnion.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01714973 is a Phase 1 study that has completed, run by Noveome Biotherapeutics, formerly Stemnion. The registered enrollment target is 20 participants.
The verdict
NCT01714973, a Phase 1 study, has completed, sponsored by Noveome Biotherapeutics, formerly Stemnion.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and efficacy of ST266 in treating radiation burns of the skin in patients undergoing treatments for breast cancer and to compare ST266 treated burns with those treated with saline placebo controls.
Interventions
- BIOLOGICAL ST266
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714973
The ClinicalTrials.gov registry entry for NCT01714973 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noveome Biotherapeutics, formerly Stemnion, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ST266 is the first listed.
NCT01714973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714973 about?
NCT01714973 is a clinical study titled "Study of ST266 Versus Saline in Treating Skin Irritation From Radiation". The objective of this study is to evaluate the safety and efficacy of ST266 in treating radiation burns of the skin in patients undergoing treatments for breast cancer and to compare ST266 treated burns with those treated with saline placebo controls.
What is the current status of trial NCT01714973?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2012-10. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01714973?
The interventions under investigation include: ST266 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01714973?
This trial is sponsored by Noveome Biotherapeutics, formerly Stemnion, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.